The structure and role of CR1 complement receptor in physiology;Budowa i rola receptora CR1 układu dopełniacza w fizjologii

Polski Merkuriusz Lekarski

Volumn 28, Issue 163, 2010, Pages 79-83

  Rochowiak, A ^a   Niemir, Z I ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

C3bR; CD35; Complement; CR1; The Knops blood group antigens

Indexed keywords

BLOOD GROUP ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR;

ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; CHEMISTRY; ERYTHROCYTE; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; INFECTION; METABOLISM; PHYSIOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; BLOOD GROUP ANTIGENS; ERYTHROCYTES; HUMANS; INFECTION; POLYMORPHISM, GENETIC; RECEPTORS, COMPLEMENT 3B;

EID: 76749109419     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Albert S., Marques G., Camprubi S. i wsp.: C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect. Immun., 1993, 61, 852-860.
2. Arora M., Jain D., Dinda A. K. i wsp.: Reduced CR1 expression on erythrocytes of idiopathic focal-segmental glomerulosclerosis patients. Nephron, 1998, 79, 365-366.
3. Birmingham D. J., Irshaid F., Gavit K. F. i wsp.: A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding. Mol. Immunol., 2007, 44,3510-3516.
4. Cockburn J. A., Mackinnon M. J., O'Donnell A. i wsp.: A human complement receptor 1 polymorphism that reduces Plasmodium falciparum ro-setting confers protection against severe malaria. Proc. Natl. Acad. Sci. U.S.A., 2004, 101, 272-277.
5. Cornacoff J. B., Hebert L. A., Smead W. L. i wsp.: Primate erythrocyte-immune complex-clearing mechanism. J. Clin. Invest., 1983, 71, 236-47.
6. Cornillet P. Gredy P., Pennaforte J. L. i wsp.: Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus. Clin. Exp. Immunol., 1992, 89, 22-25.
7. Corvetta A., Pomponio G., Bencivenga R. i wsp.: Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus, and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy. J. Rheumatol., 1991, 18, 1021-1025.
8. Cosio F. G., Shen X. P., Birmingham D. J. i wsp.: Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J. Immunol., 1990, 145, 4198-4206.
9. Couser W. G., Johnson R. J., Young B. A. i wsp.: The effects of soluble recombinant complement receptor 1 on complement mediated experimental glomerulonephritis. J. Am. Soc. Nephrol., 1995, 5, 1888-1894.
10. Currie M. S., Vala M., Pisetsky D. S. i wsp., Correlation between erythrocyte CR1 reduction and other blood proteinase markers in patients with malignant and inflammatory disorders., Blood, 1990, 75, 1699-1704.
11. Danielsson C. Pascual M., French L. i wsp.: Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. Eur. J. Immunol., 1994, 24, 2725-2731.
12. Da Silva R. P., Hall B. F., Joiner K. A. i wsp.: CR1, the C3 receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J. Immunol., 1989, 143, 617-622.
13. Dykman T. R., Hatch J. A., Aqua M. S. i wsp.: Polymorphism of the C3b/C4b receptor (CR1): characterization of a fourth allele. J. Immunol., 1985, 134, 1787-1789.
14. Fingeroth J. D., Heath M. E., Ambrosino D. M. i wsp.: Proliferation of resting B cells is modulated by CR2 and CR1. Immunol. Lett, 1989, 21, 291-301.
15. Ghiran I., Barbashov S. F., Klickstein L. B. i wsp.: Complement receptor 1/CD35 is a receptor for Mannan-binding lectine. J. Exp. Med., 2000, 192, 1797-1808.
16. Hamer I., Paccaud J. P., Belin D. i wsp.: Soluble form of complement C3b/C4b receptor (CR1) results from proteolytic cleavage in the C-terminal region of CR1 transmembrane domain. Biochem. J., 1998, 29, 183-190.
17. Hansen S., Holmskov U.: Structural aspects of collectins and receptors for collectins. Immunobiology, 1998, 199, 165-89.
18. Holers V. M., Chaplin D. D., LeyKam J. F. i wsp.: Human complement C3b/C4b receptor mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism. Proc. Natl. Acad. Sci., 1987, 84, 2459-2463.
19. Holme E., Fyfe A., Zoma A. I wsp.: Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. Clin. Exp. Immunol., 1986, 63, 41-48.
20. Jakóbisiak M.: Układ dopełniacza. - w - Goła̧b J., Jakóbisiak M., Lasek W. (red.): Immunologia. Wydawnictwo Naukowe PWN Warszawa, 2002, 11, 118-130.
21. Jozsi M., Prechl J., Bajtay Z. i wsp.: Complement receptor type 1 (CD35) mediates inhibitory signals in human B lymphocytes. J. Immunol., 2002, 168, 2782-2788.
22. Khera R., Das N.: Complement receptor 1: Disease associations and therapeutic implications. Mol. Immunol., 2009, 46, 761-772.
23. Klaska I., Nowak J. Z.: Rola układu dopełniacza w fizjologii i patologii. Postȩpy Hig. Med. Dośw., 2007, 61, 167-177.
24. Klickstein L. B., Barbashov S. F., Liu T. i wsp.: Complement receptor type 1 is a receptor for C1q. Immunity, 1997, 7, 345-355.
25. Kraus S., Fishelson Z.: Cell desensitization by sublytic C5b-9 complexes and calcium ionophores depends on the activation of protein kinase. C. Eur. J. Immunol., 2000, 30, 1272-1280.
26. Lublin D. M., Griffith R. C., Atkinson J. P.: Influence of glycosylation on allelic and cell-specific Mr variation, receptor processing, and ligand binding of the human complement C3b/C4b receptor. J. Biol. Chem., 1986, 261, 5736-44.
27. Matsushita M., Thiel S., Jensenius J. C. i wsp.: Proteolytic activities of two types of mannowe-binding lectin-associated serine protease. J. Immunol., 2000, 165, 2637-42.
28. Morgan B. P., Marchbank K. J., Longhi M. P. i wsp.: Complement: central to innate immunity and bridging to adaptive responses. Immunol. Lett., 2005, 97,171-179.
29. Moulds J. M., Kassambara L., Middleton J. J. i wsp.: Identification of complement receptor one (CR1) polymorphism in West Africa. Genes Immun., 2000, 1, 325-329.
30. Moulds J. M., Nickells M. W., Moulds J. J. i wsp.: The C3b/CC4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group sera. J. Exp. Med., 1991, 173, 1159-1163.
31. Moulds J. M., Reveille J. D., Arnett F. C.: Structural polymorphism of complement receptor 1 (CR1) in systemic lupus erythematosus (SLE) patient and normal controls of three ethnic groups. Clin. Exp. Immunol., 1996, 105, 302-305.
32. Moulds J. M., Thomas B. J., Doumbo O. i wsp.: Identification of the Kna/Knb polymorphism and a method for Knops genotyping. Transfusion, 2004, 44, 164-169.
33. Moulds J. M., Zimmerman P. A., Doumbo O. K. i wsp.: Molecular identification of Knops blood group polymorphism found in long homologous region D of complement receptor 1. Blood, 2001, 97, 2879-2885.
34. Nangaku M.: Complement regulatory proteins in glomerular diseases. Kidney Int., 1998, 54, 1419-1428.
35. Nauta A. J., Roos A., Dana M. R.: A regulatory role of complement in innate immunity and autoimmunity. Int Arch. Allergy Immunol., 2004, 134, 310-323.
36. Nicholson-Weller A., Halperin J. A., Membrane signaling by complement C5b-9, the membrane attack complex., Immunol. Res., 1993, 12, 244-257.
37. Nielsen C. H., Marquart H. V., Prodinger W. M. i wsp.: CR2-mediated activation of the complement alternative pathways results in formation of membrane attack complexes on the human B cell surface. Immunology, 2001, 104, 418-422.
38. Nielsen C. H., Pedersen M. L., Marquart H. V. i wsp.: The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripherial human B cells. Eur. J. Immunol., 2002, 32, 1359-1367.
39. Pascual M., Duchosal M. A., Steiger G. i wsp.: Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes. J. Immunol. 1993, 151, 1702-1711.
40. Pascual M., Steiger G., Sadallah S. i wsp.: Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes. J. Exp. Med., 1994, 179, 889-899.
41. Rao N., Ferguson D. J., Lee S. F. i wsp.: Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J. Immunol., 1991, 146, 3501-3507.
42. Ripoche J., Sim R. B.: Loss of complement receptor type 1(CR1) on ageing of erythrocytes. Studies of proteolytic release of the receptor. Biochem. J., 1986, 235, 815-21.
43. Rodgaard A., Christensen L. D., Thomsen B. S. i wsp.: Complement receptor type 1 (CR1, CD35) expression on peripheral T lymphocytes: Both CD4- and CD8-positive cells express CR1. Complement Inflamm., 1991, 8, 303-309.
44. Ross G. d., Lambris J. D., Cain J. A. i wsp.: Generation of three different fragments of bound C3 with purified factor I or serum. II. Requirements for factor H vs. CR1 cofactor activity. J. Immunol., 1982, 129, 2051-2060.
45. Rowe J. A., Rogerson S. J., Raza A. i wsp.: Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in resetting in field isolates. J. Immunol., 2000, 165, 6341-6346.
46. Sato T., van Dixhoorn M. G., Prins F. A. i wsp.: The terminal sequence of complement plays an essential role in antibody-mediated renal cell apoptosis. J. Am. Soc. Nephrol., 1999, 10, 1242-1252.
47. Schorlemmer H. U., Hofstaetter T., Seiler F. R. i wsp.:, Phagocytosis of immune complexes by human neutrophils and monocytes: relative importance of Fc and C3b receptors. Behring Inst. Mitt., 1984, 76, 88-97.
48. Seelen M. A., Trouw L. A., Van Der Hoorn J. W. A. i wsp.: Autoantibodies against mannose-binding lectin in systemic lupus erythematosus. Clin. Exp. Immunol., 2003, 134, 335-343.
49. Thieblemont N., Haeffner-Cavaillon N., Ledur A. i wsp.: CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsoninized HIV independently of CD4. Clin. Exp. Immunol., 1993, 92, 106-113.
50. Trouw L. A., Seelen M. A., Daha M. R.: Complement and renal disease. Mol. Immunol., 2003, 40, 125-134.
51. Van Dyne S., Holers M. V., Lublin D. M. i wsp.: The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus. Clin. Exp. Immunol., 1987, 68, 570-579.
52. Walport M. J., Ross G. D., Mackworth-Young C. i wsp.: Family studies of erythrocyte complement type 1 levels: reduced levels in patient with SLE are acquired, not inherited. Clin. Exp. Immunol., 1985, 59, 547-54.
53. Weis J. H., Morton C. C., Bruns G. A. P. i wsp.: A complement receptor locus: genes encoding C3b/C4b receptor and Cad/Epstein-Barr virus receptor map to 1q32. J. Immunol., 1987, 138, 312-5.
54. Weisman H. F., Bartow T., Leppo M. K. i wsp.: Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science, 1990, 249, 146-151.
55. Weiss L., Fischer E., Haeffner-Cavaillon N. i wsp.: The human C3b receptor (CR1). Adv. Nephrol. Necker Hosp., 1989, 18, 249-269.
56. 2+-initiated activation of cellular protein kinases. J. Biol. Chem., 1987, 262, 13674-13681.
57. Wilson J. G., Murphy E. E., Wong W. W. i wsp.: Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J. Exp. Med., 1986, 164, 50-59.
58. Wilson J. G., Wong W. W., Murphy III E. E. i wsp.: Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene. J. Immunol., 1987, 138, 2708-2710.
59. Wong W. W., Cahill J. M., Rosen M. D. i wsp.: Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele. J. Exp. Med., 1989, 169, 847-63.
60. Wong W. W., Farrell S. A.: Proposed structure of the F′ allotype of human CR1. Loss of a C3b binding site may be associated with altered function. J. Immunol., 1991, 146, 656-662.
61. Xiang L., Rundles J. R., Hamilton D. R. i wsp.: Quantitative alleles of CR1: coding sequence analysis and comparison of haplotypes in two ethnic groups. J. Immunol., 1999, 163, 4939-4945.
62. Yoon S. H., Fearon D. T.: Characterisation of soluble form of the C3b/C4b receptor (CR1) in human plasma. J. Immunol., 1985, 134, 3332-8.